Skip to main content

Site notifications

Guideline on the clinical evaluation of medicinal products indicated for the prophylaxis or treatment of respiratory syncytial virus (RSV) disease

We have adopted this International Scientific Guideline - EMA/CHMP/257022/2017 

Help us improve the Therapeutic Goods Administration site